Journal
JOURNAL OF CLINICAL MEDICINE
Volume 11, Issue 19, Pages -Publisher
MDPI
DOI: 10.3390/jcm11195626
Keywords
statin therapy; viral infection; epidemiology; cohort study; propensity score matching
Categories
Funding
- Taiwan Ministry of Health andWelfare Clinical Trial Center [MOHW110-TDU-B-212-124004]
- China Medical University Hospital [DMR-111-105]
Ask authors/readers for more resources
This study found a significant association between statin therapy and a reduced risk of viral infection in patients with hyperlipidemia, regardless of age, gender, and treatment duration.
Statins exert cholesterol-independent beneficial effects, including immunomodulatory effects. In this study, we attempted to investigate the association between statin therapy and the risk of viral infection. We conducted a retrospective cohort study using data from Taiwan's National Health Insurance Research Database. We identified patients with hyperlipidemia and divided them into two cohorts: statin users and statin nonusers. A 1:1 propensity score matching was conducted between the two cohorts, and a Cox proportional hazards model was used to evaluate the risk of viral infection. Overall, a total of 20,202 patients were included in each cohort. The median follow-up durations were 4.41 and 6.90 years for statin nonusers and users, respectively. The risk of viral infection was 0.40-fold (95% confidence interval = 0.38-0.41) in statin users than in statin nonusers after adjustment for potential confounders. Statin treatment was associated with a significantly lower risk of viral infection in all age groups older than 18 years in both men and women. Moreover, the risk of viral infection substantially reduced as the duration of statin treatment increased. Our findings suggest that statin therapy is associated with a significantly lower risk of viral infection in patients with hyperlipidemia.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available